Sigyn Therapeutics (SIGY) Change in Taxes (2020 - 2025)
Sigyn Therapeutics (SIGY) posted Change in Taxes of $93645.0 for Q3 2025, down 48.24% sequentially from $180939.0 in Q2 2025, and down 65.12% YoY from $268491.0 in Q3 2024.
Sigyn Therapeutics (SIGY) Change in Taxes (2020 - 2025) Analysis & Trends
Sigyn Therapeutics has reported Change in Taxes for 6 years, with the latest figure at $93645.0 in Q3 2025.
- Quarterly Change in Taxes fell 65.12% year-over-year to $93645.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $518087.0 (down 59.96% YoY) and the FY2024 annual result came in at $1.1 million, up 54.08% from the prior year.
- Change in Taxes eased to $93645.0 in Q3 2025 per SIGY's latest filing, from $180939.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $415491.0 in Q2 2024 and troughed at -$43362.0 in Q4 2021.
- A 5-year average of $130551.6 and a median of $121751.5 in 2024 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2021 and 2024: Change in Taxes slumped 215.06% in 2021, then surged 2499.16% in 2024.
- Over 5 years, Change in Taxes stood at -$43362.0 in 2021, then rose by 8.57% to -$39646.0 in 2022, then soared by 917.25% to $324006.0 in 2023, then sank by 66.87% to $107329.0 in 2024, then declined by 12.75% to $93645.0 in 2025.
- According to Business Quant data, Change in Taxes over the past three periods registered $93645.0, $180939.0, and $136174.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 93,645.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 93,645.00 |
| Sep 30, 2025 | 93,645.00 |
| Jun 30, 2025 | 180,939.00 |
| Jun 30, 2025 | 180,939.00 |
| Mar 31, 2025 | 136,174.00 |
| Mar 31, 2025 | 136,174.00 |
| Dec 31, 2024 | 107,329.00 |
| Dec 31, 2024 | 107,329.00 |
| Sep 30, 2024 | 268,491.00 |
| Sep 30, 2024 | 268,491.00 |
| Jun 30, 2024 | 415,491.00 |
| Jun 30, 2024 | 415,491.00 |
| Mar 31, 2024 | 285,908.00 |
| Mar 31, 2024 | 285,908.00 |
| Dec 31, 2023 | 324,006.00 |
| Dec 31, 2023 | 324,006.00 |
| Sep 30, 2023 | 218,846.00 |
| Sep 30, 2023 | 218,846.00 |
| Jun 30, 2023 | 145,278.00 |
| Jun 30, 2023 | 145,278.00 |